To decelerate by more than 10% new tools will be needed and so investing in research becomes essential. We need to optimise the use of all the tools that are currently available - BCG vaccine, INH prophylaxis, rapid molecular testing, optimum treatment regimens-- and above all hold governments accountable for universal health coverage and social/financial protection for people with TB."
Shobha Shukla, CNS (Citizen News Service)
- Shared under Creative Commons (CC) Attribution License
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
